ARCHIVES

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Waldmann, Columbia, Netherland, Receive Bristol-Myers Awards

April 17, 1992

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

More DCT Concepts Approved By Advisors

July 10, 1992

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

Feinstein Reintroduces New National Cancer Act

June 13, 2003